Thymic stroma and TFII-I: towards new targeted therapies.
Saved in:
| Title: | Thymic stroma and TFII-I: towards new targeted therapies. |
|---|---|
| Authors: | Manti PG; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy. Electronic address: Pierluigi.manti@ieo.it., Trattaro S; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy., Castaldi D; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy., Pezzali M; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy., Spaggiari L; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Division of Thoracic Surgery, European Institute of Oncology-IRCSS, Via Ripamonti 435, 20141 Milan, Italy., Testa G; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy. Electronic address: Giuseppe.testa@ieo.it. |
| Source: | Trends in molecular medicine [Trends Mol Med] 2022 Jan; Vol. 28 (1), pp. 67-78. Date of Electronic Publication: 2021 Dec 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 100966035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1471-499X (Electronic) Linking ISSN: 14714914 NLM ISO Abbreviation: Trends Mol Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34865984 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Thymic stroma and TFII-I: towards new targeted therapies. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Manti+PG%22">Manti PG</searchLink>; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy. Electronic address: Pierluigi.manti@ieo.it.<br /><searchLink fieldCode="AU" term="%22Trattaro+S%22">Trattaro S</searchLink>; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Castaldi+D%22">Castaldi D</searchLink>; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Pezzali+M%22">Pezzali M</searchLink>; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Human Technopole, Viale Rita Levi-Montalcini 1, 20157 Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Spaggiari+L%22">Spaggiari L</searchLink>; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy; Division of Thoracic Surgery, European Institute of Oncology-IRCSS, Via Ripamonti 435, 20141 Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Testa+G%22">Testa G</searchLink>; Department of Experimental Oncology, European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Via Adamello 16, 20139, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9, 20122 Milan, Italy. Electronic address: Giuseppe.testa@ieo.it. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100966035%22">Trends in molecular medicine</searchLink> [Trends Mol Med] 2022 Jan; Vol. 28 (1), pp. 67-78. <i>Date of Electronic Publication: </i>2021 Dec 02. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Ltd%22">Elsevier Science Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100966035 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-499X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214714914%22">14714914 </searchLink><i>NLM ISO Abbreviation: </i>Trends Mol Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34865984 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.molmed.2021.10.008 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 67 Titles: – TitleFull: Thymic stroma and TFII-I: towards new targeted therapies. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Manti PG – PersonEntity: Name: NameFull: Trattaro S – PersonEntity: Name: NameFull: Castaldi D – PersonEntity: Name: NameFull: Pezzali M – PersonEntity: Name: NameFull: Spaggiari L – PersonEntity: Name: NameFull: Testa G IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 01 Text: 2022 Jan Type: published Y: 2022 Identifiers: – Type: issn-electronic Value: 1471-499X Numbering: – Type: volume Value: 28 – Type: issue Value: 1 Titles: – TitleFull: Trends in molecular medicine Type: main |
| ResultId | 1 |